Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

GoHealth (GOCO) EBIAT (2019 - 2025)

GoHealth (GOCO) has disclosed EBIAT for 7 consecutive years, with -$273.2 million as the latest value for Q4 2025.

  • Quarterly EBIAT fell 1393.8% to -$273.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$645.8 million through Dec 2025, down 1123.92% year-over-year, with the annual reading at -$497.8 million for FY2025, 6700.86% down from the prior year.
  • EBIAT hit -$273.2 million in Q4 2025 for GoHealth, up from -$313.9 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $21.1 million in Q4 2024 to a low of -$313.9 million in Q3 2025.
  • Historically, EBIAT has averaged -$60.8 million across 5 years, with a median of -$34.6 million in 2021.
  • Biggest five-year swings in EBIAT: soared 1020.58% in 2024 and later tumbled 4733.48% in 2025.
  • Year by year, EBIAT stood at -$87.4 million in 2021, then increased by 29.72% to -$61.4 million in 2022, then surged by 96.26% to -$2.3 million in 2023, then skyrocketed by 1020.58% to $21.1 million in 2024, then plummeted by 1393.8% to -$273.2 million in 2025.
  • Business Quant data shows EBIAT for GOCO at -$273.2 million in Q4 2025, -$313.9 million in Q3 2025, and -$54.3 million in Q2 2025.